Corresponding author: Dr. Erick Alejandro Ramírez Pérez. Hospital Ángeles Mocel. Gelati 29, San Miguel Chapultepec, consultorio 401B, C.P. 11850. México D.F, México. Telephones: (01 55) 5278 2300, (01 55) 5278 2300. E-mail: [email protected] 1 Urologist, Hospital Ángeles Mocel y CEU México. Mexico City, Mexico. 2 Urologist, Hospital Ángeles Mocel. Mexico City, Mexico. 3 Urologist, Hospi...

INTRODUCTION Peyronie's disease (PD) has significant effect on patients and their partners. We provide a current review of the epidemiology as well as the nonsurgical and surgical treatment of PD. MATERIALS AND METHODS Review of literature pertaining to PD with focus on epidemiology and treatment options. CONCLUSION PD is common and likely underreported. The availability of new and highly e...

The objective of intralesional pharmacotherapy in the treatment of Peyronie's disease is to deliver large doses of pharmacologic agents that can have a local effect on wound remodeling, with minimal side effects. Guidelines for the treatment of peyronie's disease published in the Journal of Sexual Medicine and the European Association of Urology offer no grade A evidence of efficacy with multip...